Category: Covid19

16 Jul 2021

Curated GI articles July 15th, 2021: Gastro Health vs. GI Alliance vs. PE GI Solutions: 7 comparisons to know

Curated GI articles July 15th, 2021:
Gastro Health vs. GI Alliance vs. PE GI Solutions: 7 comparisons to know
Gastro Health vs. GI Alliance vs. PE GI Solutions: 7 comparisons to know (Becker’s GI & Endoscopy)
Private equity-backed Gastro Health, GI Alliance and PE GI Solutions are major players in the gastroenterology industry. Here’s how the companies stack up across seven areas.
How digital pathways are changing healthcare (pharmaphorum)
Digital technologies are proving their value by allowing for better care, improved adherence and a more connected ecosystem between doctors, patients and pharma.
AGA Updates Recs For Refractory H. pylori Infection (Gastroenterology & Endoscopy News)
Patients who fail an initial regimen should receive an empirical trial of an appropriately tailored second regimen instead of going directly to susceptibility testing.
Women in Healthcare Are Paid Far Less Than Men, Study Shows (The Swaddle)
A new study found a “pronounced gender pay gap” in healthcare (includes gastroenterology), indicating the medical field isn’t immune from the disparities in pay across gender prevalent in society.
Private equity-backed GI practices: 6 recent updates (Becker’s GI & Endoscopy)
From securing a $90 million investment to expanding to Colorado, Southlake, Texas-based GI Alliance and Miami-based Gastro Health have had a busy month. Here are six recent updates from private equity-backed GI practices.
Obesity links to increased risk for Crohn’s disease (Healio)
Obesity correlated with an increased risk for older-age onset Crohn’s disease but not ulcerative colitis, according to research published in Clinical Gastroenterology and Hepatology.
PPIs Could Be Bad News for Oral Cancer Therapies (Medscape)
GIs may want to be mindful of prescribing PPIs for patients with cancer because they may adversely affect concomitant oral therapies.
Ryan Ungaro, MD: Managing IBD During COVID-19 (HCP Live)
A trio of clinicians recently came together to present data and expertise on a variety of issues related to inflammatory bowel disease (IBD) treatments.
Geisinger partners with EarlySign for AI algorithms to spot chronic disease (Healthcare IT News)
A multi-year agreement with the machine learning company will start with a tool to identify high-risk GI patients, eventially expanding to other high-burden diseases.
The effectiveness of using an abdominal binder during colonoscopy (Taylor & Francis Online)
In this study, the effectiveness of using an abdominal binder (AB) during colonoscopy on procedure time and colonoscopy outcomes was investigated.
Medicare Proposes Direct Payments to PAs, Telehealth Expansion (Medscape)
Medicare intends next year to allow physician assistants (PAs) to begin directly billing for their work and to expand coverage of telehealth services.
Double trouble: a pandemic of obesity and COVID-19 (The Lancet)
Obesity has emerged as a strong risk factor for severe disease during the COVID-19 pandemic; several studies have shown that individuals with COVID-19 and obesity have an increased risk of severe disease.
CMS aims to end coinsurance when CRC screenings become diagnostic tests by 2030 (Becker’s GI & Endoscopy)
CMS plans to phase out coinsurance for colorectal cancer screenings when physicians identify a polyp for removal, which currently are categorized as diagnostic tests.
COVID-19 in gastroenterology and hepatology: Where will we be? (Wiley Online Library)
The COVID-19 pandemic showed us there is a great potential to optimize our communication with patients and to increase efficacy of triage when faced with limited endoscopy services.
Trial Data May Signal Paradigm Shift In GERD, Esophageal Illnesses (Gastroenterology & Endoscopy News)
Many esophageal diseases, including gastroesophageal reflux, appear to be driven by a dysregulated esophageal microbiome, new research indicates.
Q&A: Addressing the unmet need for equitable health care access (Healio)
Despite representing 13% of the general population, Black physicians are few in the field of gastroenterology and hepatology (> 4%) and accounted for less than 7% of the medical student population.
Latest Multi-Society Reprocessing Guidelines Aim to Follow the Evidence (Gastroenterology & Endoscopy News)
Increased research on reprocessing of endoscopes triggered by infectious outbreaks related to contaminated duodenoscopes since 2014 provided data for the guidelines authors to develop a comprehensive document.
Malnutrition persistent in patients with COVID-19 at 3- and 6-months post-infection (Healio)
3,229 of the hospitalized patients with COVID-19 had GI manifestations and 715 patients had 788 distinct GI manifestations and 3 and/or 6 months outpatient follow up data post-discharge.
Did Getting a Colonoscopy Lead to Cleaner Living? (MedPage Today)
Individuals who underwent endoscopic screenings said they started to live a healthier lifestyle afterwards, especially for those with severe findings, researchers found.
Severe food avoidance, restriction reduces quality of life in IBS (Healio)
Patients with IBS who engaged in severe food avoidance and restriction experienced more severe IBS symptoms and a reduced quality of life, according to study results.
Can Gut Changes Predict Celiac Disease? (Medscape)
Changes in the gut microbiome are present in infants at risk of developing celiac disease (CD) long before they actually develop the disease, a finding that may pave the way for novel treatment and prevention strategies.
Disease Surveillance With Every Flush: Introducing the Smart Toilet (Gastroenterology & Endoscopy News)
Toilets enabled with AI can analyze stool samples for signs of acute or chronic gastrointestinal disease, such as bleeding, infections or even inflammatory bowel disease.
Fecal Transplantation, Boosted by Fiber, Improves Insulin in Obesity (Medscape)
New research shows that a noninvasive approach ― with an oral capsule formulation ― combined with fiber supplementation significantly improved insulin sensitivity among those with severe obesity and metabolic syndrome.
Geneoscopy Enrolls First Patients in CRC-PREVENT U.S. Pivotal Trial (PR Newswire)
Initial clinical study demonstrated high sensitivity of its multifactor RNA-FIT assay compared with colonoscopy findings, demonstrating 95% sensitivity for colorectal cancer and 62% sensitivity for advanced adenomas.
NEC’s AI Supports Doctors to Determine If Colorectal Lesions Are Potentially Neoplastic (Business Wire)
The Cx20 software connects and interacts with existing endoscopic equipment and automatically notifies users if a lesion is possibly neoplastic based on images captured during endoscopy procedures.
Will PPE Practices in Endoscopy Change Permanently After COVID-19? (Gastroenterology & Endoscopy News)
Will endoscopists keep their new habits when it comes to personal protective equipment (PPE) once the COVID-19 pandemic has ended? A survey of Canadian clinicians suggests they will.
Phoenix hospital adds AI-powered colonoscopy system (Becker’s GI & Endoscopy)
The Cancer Treatment Centers of America Phoenix implemented Medtronic’s GI Genius. The artificial intelligence device helps detect polyps during colonoscopies.
FDA advisory committee unanimously agrees donor liver portable system is safe, effective (Healio)
The FDA voted unanimously that a portable system for near-normothermic continuous perfusion of donor livers with perfusate was safe and effective.

More Hot headlines in GI
Coming of age: AI in GI endoscopy, impact on optical diagnosis and training
(ESGE Endoscopy)

Unlocking the ‘gut microbiome’ – and its massive significance to our health
(The Guardian)

UnitedHealth reports $4.3B in profit in Q2, down from massive Q2 2020 haul
(Fierce Healthcare)

Update 2021: COVID-19 from the perspective of gastroenterology (PubMed)

52 Women-Led Startups Driving The Future Of HealthTech And FemTech (Forbes)

[Podcast] To End Burnout, Doctors Must Change the Culture of Medicine (Medscape)

The Most Famous Artist Mints First NFT from Human Fecal Matter to Fund Gut-Brain Research Grant (PR Newswire)

ProciseDx Raises $13M to Commercialize Point-of-Care Platform, GI Tests (GenomeWeb)

[VIDEO] Older IBD patients use more aminosalicylate monotherapy (Healio)

Microsoft taps Teladoc to integrate telehealth into Teams app (Fierce Healthcare)

Managing Fatigue in IBD Patients Is Crucial for Quality of Life (MedPage Today)

CMS announces new director for Center of Medicare (Healthcare Finance)

CrossBridge Health acquires Geisinger-developed PACER software (PR Newswire)

Health systems-backed Truveta closes $95M to fund its data analysis platform
(Fierce Healthcare)

Gut Microbiome Affected by Genetics More Than Once Thought (Genetic Engineering & Biotechnology News)

Should we trust big tech with our health data? (BBC)

FDA: Johnson & Johnson COVID-19 vaccine tied to Guillain-Barré syndrome (Healio)

Dr. Atul Gawande is Biden’s pick for global health position (Becker’s Hospital Review)

Videos: Interviews with GI Leaders  (NextServices)

_
COVID-19: The Way Forward for Gastroenterology Practices
COVID-19 is a double whammy of both clinical and business disruption. This ebook will help you explore possible scenarios and be a guide in your plans for the future.
button_download
09 Jul 2021

Curated GI articles July 8th, 2021: Penfund announces $85 million investment in Gastro Health

Curated GI articles July 8th, 2021:
Penfund announces $85 million investment in Gastro Health
(Webinar) Scope Forward: The Future of GI is Now in Your Hands (Sonic Incytes)
Join Praveen and gastroenterologist Dr. Bradley Sklar to discover insights and practical advice for the industry to thrive, not just survive in the coming decade.
Gastro Health Expands Presence in Ohio (Gastro Health)
Gasto Health has partnered with a group of 17 hospital-based gastroenterologists who will now become part of Gastro Health – Ohio, also known as Ohio GI.
South Suburban Gastroenterology Joins GI Alliance (PR Newswire)
GI Alliance expands in Illinois and the Greater Chicago Area through a partnership with South Suburban Gastroenterology. GI Alliance now represents over 1,000 providers across ten states.
Penfund Announces US$85 million Investment in Gastro Health (GlobeNewswire)
An independent provider of junior capital to North American middle market companies, announced the completion of a second lien debt and equity co-investment in Gastro Health, LLC.
FOMAT Medical Research Partners With Santa Maria Gastroenterology Medical Group (KPVI)
The partnership broadens the reach of medical research across Central California, making hard-to-reach clinical trials readily available for hundreds of thousands of patients.
Lessons Learned on Gastroenterology Future During COVID-19 Pandemic (HCPLive)
A team, led by Fernando Magro, University of Porto, evaluated how the COVID-19 pandemic impacted the quality of health care services for gastroenterology patients.
15 insights on GI net worth, debt & compensation (Becker’s GI & Endoscopy)
Fifty percent of gastroenterologists who took financial hits because of the pandemic expect their income to return to normal in this year.
Twitter Found to Be Key GI Educational Tool (Gastroenterology & Endoscopy News)
Twitter is fast becoming a central way of imparting knowledge in gastroenterology for students and veteran practitioners alike, according to findings from a survey.
Hepatic Steatosis Is Associated with Increased Disease Severity and Liver Injury in COVID-19 (PubMed)
A study indicated hepatic steatosis (HS) was associated with increased disease severity and transaminitis in COVID-19. HS may be relevant in predicting risk of complications related to COVID-19.
Chemotherapy destabilizes gut microbiome in cancer patients (News-Medical.Net)
New research in BMC Cancer has shown myelosuppressive chemotherapy destabilizes gut microbiome in patients with solid organ cancers.
Clostridioides difficile: 2 Sets of Guidelines Disagree (Medscape)
With two sets of recommendations being published within a month of each other, clinicians may find themselves trying to reconcile some of the conflicts between the two guidelines.
Endoscopic sleeve gastroplasty may be safe for managing weight loss in NASH (Healio)
Endoscopic sleeve gastroplasty in patients with nonalcoholic steatohepatitis vs. life-style intervention alone was safe and effective for achieving weight loss correlated with significant improvements.
Minnesota GI company building ASC (Becker’s GI & Endoscopy)
MNGI Digestive Health is building a new clinic and ASC in Vadnais Heights, Minnesota. The project is slated to open in April 2022.
Q&A: LinZess reduces bloating, pain in patients with IBS-C (Healio)
Compared with placebo, LinZess significantly decreased abdominal symptoms such as bloating, discomfort and pain in patients with IBS-C, according to results published in the AJG.
One GI Symptom Stuck Around Months After Severe COVID (MedPage Today)
While most GI symptoms resolved for patients hospitalized with COVID-19, inability to gain weight persisted for months, researchers found in a retrospective study.
Probiotic ‘yeast robots’ may one day treat IBD (Medical News Today)
Researchers have developed a multifunctional “designer” probiotic to treat various facets of IBD. It reduces inflammation, reverses tissue damage, and restores the gut microbiome in a mouse model.
Olympus Supports New Recommendation to Begin Colorectal Cancer Screenings at Age 45 
(PR Newswire)
Olympus announced its support of the new recommendation issued by the United States Preventive Services Task Force to begin colorectal cancer screenings for all individuals beginning at age 45.
Antibiotic Linked to Rise in Early-Onset Colon Cancer? (Medscape)
Exposure to antibiotics appears to be associated with the development of colon cancer, particularly in younger people, and could be contributing to the increase in early onset colorectal cancer (CRC).
Single-use endoscopy: 3 leading physicians weigh in (Becker’s Hospital Review)
Traditionally, health systems have invested in reusable endoscopy equipment, but an industrywide transition toward single-use endoscopes is gaining momentum.
New Jersey Center Implements Innovative Program For Pancreatic Cyst Surveillance (Gastroenterology & Endoscopy News)
Saint Barnabas Medical Center, N.J., has pioneered one of the first cloud-based data management platforms in the nation to identify, track and monitor patients with pancreatic cysts.
Colon Cancer Is Rising in Younger Adults. Do Sugary Drinks Play a Role? (The New York Times)
As consumption of sugar-laden drinks rose in the 1980s and ’90s, so did colorectal cancer rates among younger adults, a study in nurses found.
Study links low UVB light exposure with increased CRC risk (Becker’s GI & Endoscopy)
Areas where people have lower ultraviolet B light exposure often report higher colorectal cancer rates, according to a study published July 5 in BMC Public Health.
FIT after negative colonoscopy may reduce the risk of incident CRC: Study (Medical Dialogues)
Subsequent FIT must be scheduled after negative colonoscopy to detect missed neoplasms, thereby reducing the risk of incidence, of CRC finds a recent study.
3 biggest threats to ASCs (Becker’s ASC Review)
The power of hospital consolidation and recruiting staff continue to threaten ASC profitability in 2021. Here are the three biggest external risks to ASCs.
Progress Made in Characterizing The Microbiome of Patients With SIBO (Gastroenterology & Endoscopy News)
A sophisticated characterization of the small-bowel microbiome could aid the search for treatments for small intestinal bacterial overgrowth (SIBO).
COVID-19 Drives Digital Health Transformation, Health IT Innovation (EHR Intelligence)
COVID-19 has advanced the digital health transformation, bringing executives to drive health IT innovation with urgency for business resilience.

More Hot headlines in GI
Impact of the National Endoscopy Database (NED) on colonoscopy withdrawal time (PubMed)

July Issue of Issue of The American Journal of Gastroenterology Includes Analysis of Psychological Comorbidities and Irritable Bowel Syndrome Prognosis (Newswise)

Exact Sciences schedules second quarter 2021 earnings call (Yahoo Finance)

We’re Going to Need Smaller Scopes (and Lots of Them) (Gastroenterology & Endoscopy News)

What GI companies did in Q2: 19 notes (Becker’s GI & Endoscopy)

Black Patients with Liver Disease May Face Obstacles to Placement on the Liver Transplant Waitlist (Weill Cornell Medicine)

Advances in Nonalcoholic Fatty Liver Disease Unveiled at International Liver Congress (Managed Healthcare Executive)

If You Invested $1000 in Exact Sciences a Decade Ago, This is How Much It’d Be Worth Now (Yahoo Finance)

Novome announces phase 1 trial of GEMM cell therapy (Healio)

Osso VR takes in $27M to train surgeons using simulations (Fierce Healthcare)

Apple’s VP of health says the company works ‘like an orchestra’ (Apple Insider)

VIDEO: Telemedicine shaped future of health care during COVID-19 (Healio)

Saltzer Health names administrator of ASC, GI center (Becker’s ASC Review)

Digital health funding rockets up to $14.7B, speeding past 2020’s investment (Fierce Healthcare)

Hepatitis B does not link to increased risk for liver injury, death in COVID-19 (Healio)

Amazon is trying to persuade Aetna and other health plans to cover its medical-care service (Business Insider)

Videos: Interviews with GI Leaders  (NextServices)

_
COVID-19: The Way Forward for Gastroenterology Practices
COVID-19 is a double whammy of both clinical and business disruption. This ebook will help you explore possible scenarios and be a guide in your plans for the future.
button_download
02 Jul 2021

Curated GI articles July 1st, 2021: GI Alliance Further Expands in Utah

Curated GI articles July 1st, 2021:
GI Alliance Further Expands in Utah
GI Alliance Further Expands in Intermountain West with Utah Gastroenterology (KPVI)
GI Alliance, the nation’s largest independent gastroenterology services organization, announced expansion into Utah through a partnership with Utah Gastroenterology.
AI software may help spot early signs of oesophageal cancer (The Guardian)
Software in use at an NHS trust could prove a breakthrough in diagnosing one of the deadliest forms of cancer.
9 GI industry updates to know (Becker’s GI & Endoscopy)
GI Alliance expanded into Colorado, and Fujifilm launched an endoscopy-specific integration platform. Nine gastroenterology industry updates to know.
Gastroenterology Associates Becomes Part Of Genesis Health Group in Iowa (QuadCities.com)
The experienced providers of Gastroenterology Associates, P.C., have become part of Genesis Health Group, the largest multi-specialty provider group in the region (Iowa).
COVID-19 in gastroenterology: Where are we now? (Wiley Online Library)
Patients and healthcare systems have seen their routines changed, adopting measures to minimize the risk of infection while guaranteeing continuous medical care.
Liver cancer test algorithm identifies risk for HCC in hepatitis C (Healio)
Researchers validated a liver cancer risk test algorithm for identifying patients with chronic hepatitis C at low risk for hepatocellular carcinoma.
Micro-Tech Endoscopy Announces the Release of its New Submucosal Lifting Agent (PR Newswire)
The company expanded its EMR and ESD portfolio with the launch of its BlueBoost submucosal lift. It is a viscous submucosal injection fluid designed to increase the efficiency of resection procedures.
Woman hit with nearly $2,000 unexpected bill for colon cancer screening (CBS News)
A popular home test to screen for colon cancer has come with an unexpected bill for some people — leading to fears they may put off life-saving treatment.
Early-Onset CRC Associated With Longer Survival (Medscape)
Individuals diagnosed with primary CRC at less than 50 years of age have better survival outcomes than individuals diagnosed at 51-55 years, based on data from more than 750,000 patients.
Food Insecurity Tied to More Liver Disease Deaths (MedPage Today)
Limited or a lack of access to nutritious food led to poorer clinical outcomes in adults with advanced liver fibrosis and non-alcoholic fatty liver disease (NAFLD).
Nestlé joins Seres in deal to market microbiome drug (BioPharma Dive)
The health science unit at Nestlé may pay more than $500 million to secure commercialization rights in the U.S. and Canada for SER-109, a spore-filled capsule that targets the microbiome.
Over 40,000 previously unknown viruses found in the human gut microbiome (New Atlas)
The vast majority are unknown to science and researchers suggest understanding the novel interactions between bacteria and viruses in our microbiome could help develop future therapeutic treatments for disease.
Austin Gastroenterology opened second HyGIeaCare® Center (EIN Presswire)
Austin Gastroenterology’s second location opened for business to provide patients with HygiPrep® and HygiRelief®.
Probiotics: A Review for Clinical Use (Gastroenterology & Endoscopy News)
Although the proposed health benefits of probiotics continue to trend on social media and remain an area of active clinical research, it is clear that there is a shift toward other modalities of microbiome-based therapy.
(Podcast) Virtual Reality in GI with Brennan Spiegel, MD (Healio)
Brennan Spiegel, MD, MSHS, discusses virtual and augmented reality in gastroenterology from both a clinical and research perspective, as well as his thoughts on the future of the field.
Excited to share Apple Health Records with a doctor? (Fierce Healthcare)
Apple Health Records will allow users to choose a participating organization and select which metrics they would want to share with their doctor.
92 great gastroenterologists to know (Becker’s GI & Endoscopy)
Compiled by Becker’s, here’s a list of gastroenterologists to know from across the country so far this year.
Q&A: Trulance improves quality of life in chronic constipation, IBS-C (Healio)
Researchers observed clinically and statistically meaningful improvements with Trulance in patients with chronic idiopathic constipation and irritable bowel syndrome with constipation with reduced quality of life.
Walmart looks for healthcare advantage with insulin push (Seeking Alpha)
Walmart plans to offer a private-label version of insulin that could be attractive to millions of Americans who do not have health insurance.
14% of physicians sought new employment due to COVID-19, survey says (Becker’s ASC Review)
AMN Healthcare, B.E. Smith and Merritt Hawkins’ recent report called “Will there be a doctor in the house?” detailed physician supply, demand and staffing during COVID-19.
New Data Support De-escalating Chemotherapy in Colorectal Cancer (Medscape)
Dr. David Kerr provides his perspective on de-escalating chemotherapy in CRC based on data presented at the American Society for Clinical Oncology (ASCO) annual meeting.
Elastography, bloodwork combine for ‘super test’ to diagnose advanced liver fibrosis (Healio)
Using clinical bloodwork like FIB-4 and elastography technology in combination, researchers proposed they could better identify patients with advanced fibrosis.
Diets Engineered to Work With Your Microbiome Are Latest Startup Craze (The Wall Street Journal)
Providers of personalized nutrition assert finely tuned diets help against chronic disease; dearth of rigorous research gives pause to some in traditional medicine.
5 digital health startups that raised over $100M in June (Becker’s Health IT)
The first quarter of 2021 was digital health’s most-funded quarter to date, and investors continued the trend in the second quarter by pledging high dollar amounts.
Which physician groups will have the most power in the future? (Becker’s ASC Review)
In the value-based healthcare ecosystem, the currency will be data, and organizations with the best information will be more likely to thrive.
More Efficient Tests May One Day Replace Endoscopy (University of Houston)
In two studies, other proteins – not just blood – found elevated in colorectal cancer and inflammatory bowel disease.

More Hot headlines in GI
Alcohol-Related Diseases Increased as Some People Drank More During the COVID-19 Pandemic (JAMA)

Exact Sciences growing beyond Cologuard (BizTimes Media)

AbbVie Gastroenterology Pipeline to be Featured at the 16th Congress of European Crohn’s and Colitis Organization (PR Newswire)

Summit Health expands into N.Y. with integration of NYC gastroenterology practice (ROINJ)

Recuro Health Further Expands Digital Solution Platform (Businesswire)

Resmetirom Shows Promise for Fatty Liver in Early Analysis (Medscape)

VIDEO: Bowel movements, GI symptoms important to understanding gut microbiome (Healio)

3 approaches digital health companies are taking to improve LGBTQ care (Becker’s Health IT)

NHS to pilot blood test that identifies 50 types of cancer (Healthcare IT News)

The Most Famous Artist Mints First NFT from Human Fecal Matter to Fund Gut-Brain Research Grant (PR Newswire)

Ro’s latest acquisition adds at-home testing to its platform (Fierce Healthcare)

Testing Amazon Pharmacy: Tech giant’s clever system collides with realities of modern healthcare (GeekWire)

Thirty Madison jumps to unicorn status as it eyes expansion, payer partnerships (Fierce Healthcare)

‘Mounting’ data link red meat consumption to colorectal cancer risk, mortality (Healio)

The Pandemic Hurt Patients With Liver Disease in Many Ways (Medscape)Videos: Interviews with GI Leaders  (NextServices)

_
COVID-19: The Way Forward for Gastroenterology Practices
COVID-19 is a double whammy of both clinical and business disruption. This ebook will help you explore possible scenarios and be a guide in your plans for the future.
button_download
26 Jun 2021

Curated GI articles June 25th, 2021: Colorado Gastroenterology Joins GI Alliance

Curated GI articles June 25th, 2021:
Colorado Gastroenterology Joins GI Alliance
Simple Blood Test to Detect Colorectal Cancer (Medscape)
The new test, known as LUNAR-2 (Guardant Health), is an assay that measures circulating tumor DNA (ctDNA), and is carried out on a simple blood draw.
Colorado Gastroenterology Joins GI Alliance (PR Newswire)
GI Alliance now represents more than 1,000 providers, including over 560 gastroenterologists and physicians and 450 advanced practice providers across four regions and nine states.
Gastroenterologist revenue data: 5 stats (Becker’s GI & Endoscopy)
The Merritt Hawkins Physician Staffing Slide Rule provides information on physician revenue and demographics for various specialties.
Fujifilm Launches System Integration Platform Specifically Designed for Endoscopy Suites (PR Newswire)
Industry’s first Systems Integration platform designed specifically to enhance image and data integration in endoscopy suites.
IBD Treatment Doesn’t Lead to Severe COVID-19 Outcomes (HCP Live)
Researchers found no difference between the risk of death or mechanical ventilation based on different IBD Treatments.
‘Electronic nose’ accurately detects ovarian, pancreatic cancers (Healio)
An electronic, odor-based tool accurately distinguished pancreatic and ovarian cancer specimens from benign disease and control specimens by analyzing vapors emanating from blood samples.
Amazon launches digital health accelerator with a focus on virtual care, analytics startups (Fierce Healthcare)
The program will focus on technologies such as remote patient monitoring, data analytics, patient engagement, voice technology and virtual care.
ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections (AJG)
Defined microbiota consortia may enable a more targeted approach to treatment of the underlying dysbiosis that drives CDI.
Q&A: Posttraumatic stress symptoms afflict patients with IBD (Healio)
Survey results supported prior research that found one-quarter to one-third of patients with IBD report posttraumatic stress symptoms linked to their disease experience.
$10M awarded to Prometheus Biosciences for hitting IBD drug milestone (Becker’s GI & Endoscopy)
The funds were awarded for developing, PR600, a precision antibody for the treatment of patients with inflammatory bowel disease.
7 recent reports in liver: HCC screening, cirrhosis, DDW (Healio)
These stories include screening for hepatocellular carcinoma, antimicrobial gene burden in cirrhosis, AGA guidance on palliative care management and more.
Inpatient endoscopy delay increases 30-day readmission rates (Healio)
Inpatient endoscopy delay occurred often in a tertiary center and was a risk factor for 30-day readmission, according to a study published in Clinical Gastroenterology and Hepatology.
Optical Fiber Imaging for Next-Generation Endoscopes (Medgadget)
Researchers have developed a technique to image tissues through an ultrathin optical fiber, potentially allowing for high-resolution imaging of single cells within the body.
Restoring gut microbes missing in early life dysbiosis can reduce risk of colitis in mice (EurekAlert)
A study in mice found that microbial imbalances induced by early exposure to antibiotics could be corrected by adding back a single strain of Bacteroides to improve the dysbiosis and prevent colitis.
Prevalence Estimates of Eosinophilic GI Diseases Might Be Way Off (GI & Endoscopy News)
Researchers conducting a clinical trial suggest that current estimates of prevalence of eosinophilic gastritis (EG) and duodenitis (EoD) could be too low.
Video: Colorectal cancer survivor says regular screening made a big difference (KTVO)
In 2019, despite having no symptoms, regular CRC screening provided an early warning of a new cancer that had developed — colorectal cancer.
5 issues GI execs are obsessing over (Becker’s ASC Review)
From private-equity investment to new screening recommendations, gastroenterology leaders are focusing on several industry shifts.
Gastro Health and Hygieacare® established a strategic collaboration (EIN Presswire)
The strategic collaboration agreement follows the success of the Hygieacare Center in Ohio, with the Ohio GI practice that recently joined the Gastro Health platform.
Prevalence of NAFLD, MAFLD and Advanced Fibrosis in the U.S. (Medscape)
A panel of international experts proposed a new diagnostic entity called metabolic dysfunction-associated fatty liver disease (MAFLD).
GERDHelp™ Mobile App to Assist GERD Patients in Navigating Their Journey With Individualized Education and Support (Business Wire)
Developed in partnership with DoctorPlan®, the app utilizes data to connect patients with expert clinicians as they jointly develop individualized plans for GERD treatment.
10 gastroenterologists to know (Becker’s GI & Endoscopy)
Monthly list of influencers in gastroenterology compiled by Becker’s GI & Endoscopy.
Partnership supports a shared vision to change lives by making ‘food as medicine’ simple, effective and enjoyable (Monash University)
Developed by Monash University, the FODMAP diet protocol and corresponding App assist in the management of gastrointestinal symptoms associated with IBS.


More Hot headlines in GI
7 GI exec moves in the past month (Becker’s GI & Endoscopy)

Controversial Approval Puts Lack of Permanent FDA Chief in Spotlight (Medscape)

Coffee consumption, irrespective of its type, prevents chronic liver disease: Study (Medical Dialogues)

Progenity appoints inflammatory bowel disease clinical advisory board (Becker’s GI & Endoscopy)

Link observed between deficits in geriatric assessments, disease activity, burden in IBD (Healio)

How can health systems ensure their machine learning practices are ethical? (Healthcare IT News)

New Antireflux Technique Combines Laparoscopic, Transoral Approaches (Gastroenterology & Endoscopy News)

Weill Cornell Medicine launches $1.5B campaign to fund bench-to-bedside research in precision health, genomics (Fierce Healthcare)

Regueiro Report: Of Stem Cells and ‘Breathprints’ (Gastroenterology & Endoscopy News)

Google Health pivots from consumer to clinical with latest shakeup (DOTmed.com)

Black veterans have a higher prevalence of colorectal cancer (Healio)

North Brunswick Teen Wins Apple Scholarship for Gastro App (TAP IP LLC)

Videos: Interviews with GI Leaders  (NextServices)

_
COVID-19: The Way Forward for Gastroenterology Practices
COVID-19 is a double whammy of both clinical and business disruption. This ebook will help you explore possible scenarios and be a guide in your plans for the future.
button_download
18 Jun 2021

Curated GI articles June 17th, 2021: No overwhelming surges, but endo center traffic returning

Curated GI articles June 17th, 2021:
No overwhelming surges, but endo center traffic returning
Gastroenterology Physician Practice Management and Private Equity: Thriving in Uncertain Times 
(Clinical Gastroenterology and Hepatology )
Market forces continue to drive the consolidation wave, and these forces are highlighted by reimbursement pressures, payer negotiations, local competition, recruiting strength, and the desire to maintain practice independence.
No Overwhelming Surges, But Endo Center Traffic Is Returning (Gastroenterology & Endoscopy News)
In a survey of endoscopy clinicians, conducted by the global clinical network SERMO, 79% of respondents said COVID-19 has significantly increased waiting times in endoscopy.
Statins underused in NAFLD patients with clear indications (Healio)
Only 56% of patients with NAFLD were taking guidelines-recommended statin therapy, according to a study published in Clinical Gastroenterology and Hepatology.
COVID-19: Colorectal cancer endoscopic surveillance in IBD (The Lancet)
Data suggests that surveillance procedures, for high-risk populations such as those with inflammatory bowel disease—have been slower to recover.
Colonoscopy at 45 – Is This the Right Cut Point? (Medscape)
Lowering the starting age to 45 means about 475 additional lifetime colonoscopies per 1,000 people, and about one additional complication.
Large Study Examines Optimal Timing of Colonoscopy After Abnormal Stool-Based Test 
(Gastroenterology & Endoscopy News)
A delay of one year or longer in diagnostic colonoscopy after an abnormal stool-based screening test was significantly associated with the incidence of colorectal cancer.
How many gastroenterologists have $5M+ net worth? 5 stats (Becker’s GI & Endoscopy)
Less than 5 percent of gastroenterologists have a net worth of at least $5 million, according to Medscape’s “Physician Wealth & Debt Report 2021.”
Physicians Warm to ‘Open’ Notes Over Time: Study (Gastroenterology & Endoscopy News)
Physicians may have concerns prior to sharing their notes with patients, but most find the practice to be beneficial after the fact, a recent survey has found.
Apple wants to own the interface between you and your doctor (Fast Company)
At WWDC, the company has announced an array of features that will pit it against medical records giant Epic.
May top 7 in GI: ACG, colorectal cancer, Digestive Disease Week 2021 (Healio)
These stories include ACG guidelines for the preferred treatment of adults with Clostridioides difficile, updated recommendations for colorectal cancer screening, coverage from DDW and more.
Postoperative gastroenterology trends to know (Becker’s GI & Endoscopy)
Telemedicine and other technological advancements have changed the way gastroenterologists approach postoperative care.
Inpatient endoscopy delay increases 30-day readmission rates (Healio)
Inpatient endoscopy delay occurred often in a tertiary center and was a risk factor for 30-day readmission, according to a study published in Clinical Gastroenterology and Hepatology.
Is ulcerative colitis an autoimmune disease? (Medical News Today)
An overactive immune response causes the immune system to attack healthy tissue in the gut, leading to inflammation of the large intestine.
Anal Cancer Rates in U.S. Rose From 2001 to 2016 (Gastroenterology & Endoscopy News)
The incidence of anal cancer in the United States has increased since 2001 among people ages 50 years and older, yet declined in younger people.
New AMA policies attempt to revamp prior authorization process (Healio)
An AMA survey showed that 94% of physicians experienced care delays while waiting for a health insurance company to authorize necessary care.
UnitedHealth Group’s plan to drive more surgeries to ASCs (Becker’s ASC Review)
At-home test kits were mailed to 22,838 patients, who received follow-up reminders via text message and mailers.
New noninvasive biomarker can be used in the diagnosis of NAFLD (News Medical)
Researchers at Osaka University have identified a noninvasive biomarker that can identify patients at risk of NAFLD complications using a simple blood test.
FIT improves referral efficiency in primary care settings (Healio)
Fecal immunochemical test improved the efficiency of referrals in patients with new-onset lower gastrointestinal symptoms within a primary health care setting.
Non-Invasive Screening for Colorectal Cancer During COVID-19 Pandemic (Clinical Pain Advisor)
Stool-based screening methods for colorectal cancers helped screening rates recover to pre-pandemic levels after a drastic decline of invasive screening methods due to COVID-19.
Guidelines: Management of Moderate to Severe Crohn’s Disease (Medscape)
The AGA released guidelines for adult outpatients with moderate to severe Crohn’s disease, recommending induction and maintenance therapy with anti-TNF-alpha agents.

More Hot headlines in GI
Giiant Pharma Inc Announced the Closing of US$11m in Seed Financing to Develop Its Precision Delivery Technology Platform in Gastroenterology (Business Wire)

What it will take for ASCs to thrive in 2021: 8 exec perspectives (Becker’s ASC Review)

Gastroenterologist proposes surgery center, medical office in Minnesota: 3 details (Becker’s GI & Endoscopy)

Aetna, Anthem and Cleveland Clinic back blockchain venture (Fierce Healthcare)

Mansour A. Parsi, MD, Named Chief of Division of Gastroenterology and Hepatology (UTHSC)

WSJ leaks Apple’s digital healthcare plan (Computerworld)

4 ways machine learning is fixing to fine tune clinical nutrition (AI in Healthcare)

10 gastroenterologists to know (Becker’s GI & Endoscopy)

Fewer Than 1 in 10 Americans Meeting Dietary Fiber Recommendations (Medscape)

Amazon vs. Traditional Healthcare: Who Will Win? (Managed Healthcare Executive)

Google Health VP talks combing consumer tech with clinical needs (Digital Health)

CDC reports rise in resistant Salmonella infections (Healio)

Mount Sinai launches health tech incubator (Fierce Healthcare)

Jonathan Bush launches new digital health, data-sharing platform: 4 details (Becker’s Health IT)

AMA survey: 96% of physicians fully vaccinated against COVID-19 (Healio)

Videos: Interviews with GI Leaders  (NextServices)

_
COVID-19: The Way Forward for Gastroenterology Practices
COVID-19 is a double whammy of both clinical and business disruption. This ebook will help you explore possible scenarios and be a guide in your plans for the future.
button_download
11 Jun 2021

Curated GI articles June 10th, 2021: One of NY’s largest GI groups joins 1,600 provider Summit Health

Curated GI articles June 10th, 2021:
One of NY’s largest GI groups joins 1,600 provider Summit Health
Summit Health Adds Gotham Gastroenterology; Marks First Specialty Group Integration In New York Region (PR Newswire)
The addition of Gotham Gastroenterology,  is the first extension of Summit Health’s highly effective patient care and physician group management model in the NY region.
CRC found in ages 45 to 50 years supports USPSTF recommendation (Healio)
The occurrence of colorectal cancer in colonoscopies performed on patients aged between 45 and 50 years showed rates that approach those in ages 50 to 54 years.
New blood-based CRC test is more than 90% accurate, study says (Becker’s GI & Endoscopy)
The blood test was found to detect colorectal cancer with 92% sensitivity and 97% specificity. It also was shown to have 89% sensitivity and 97% specificity detecting early-stage cancer.
Regueiro Report: Nutrition And Psychosocial Care for IBD (Gastroenterology & Endoscopy News)
Two aspects of inflammatory bowel disease must be addressed as part of a whole-person care approach: the impact of nutrition and stress.
Medscape Physician Compensation Report 2021: The Recovery Begins (Medscape)
Almost 18,000 physicians in over 29 specialties on their income, bonuses, hours worked, greatest challenges, and the impact of COVID on their compensation.
ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury (AJG)
These recommendations, intended for use by physicians and other health care providers, suggest preferred approaches to the diagnosis and management of DILI.
Artificial Intelligence Enables New Colonoscopy Screening Method (Health IT Analytics)
Ohio State University is the first academic medical center in the nation to use a new FDA-approved AI-driven system for colonoscopy procedures.
How one company wants to train surgeons using virtual reality (Axios)
Immertec, located inside Tampa’s Armature Works, is changing the game for surgical training — making operating rooms more accessible than ever via virtual reality.
One Quarter of 30–49-Year-Olds Have Abnormal Colonoscopy Results (Medscape)
More than one quarter of colonoscopies carried out in Americans aged 30 to 49 years reveal some type of neoplasm, and slightly over 6% of these patients have advanced cancer.
Optum in the past 90 days: 10 updates (Becker’s ASC Review)
OptumCare is a fast-growing business for UnitedHealth, which plans to make Optum a $100 billion business.
Elite gastroenterologist’s path to being a champion of diversity (Stanford Medicine)
Eric Sibley, MD, PhD, professor of pediatric gastroenterology describes how the slow onset of multiple sclerosis physically changed him incrementally over many years.
Entyvio, Stelara plus immunomodulators not as effective for IBD (Healio)
Neither Entyvio nor Stelara plus immunomodulators were as effective as other therapies for inflammatory bowel disease, according to research at Digestive Disease Week.
Video: Endoscopists report effectiveness of single-use duodenoscope (Healio)
Endoscopists reported successful use of the first single-use duodenoscope for endoscopic retrograde cholangiopancreatography, Adam Slivka, MD, PhD, University of Pittsburgh, told Healio Gastroenterology.
Where Dell Medical School’s program for at-home CRC screenings stands 3 years in (Becker’s GI & Endoscopy)
At-home test kits were mailed to 22,838 patients, who received follow-up reminders via text message and mailers.
Noninvasive Tests May Enable Some Patients With NAFLD Avoid Biopsy (Medscape)
In patients in with non-alcoholic fatty liver disease (NAFLD), noninvasive test result cutoffs may help clinicians diagnose cirrhosis without liver biopsy, a new study suggests.
GI trends in preoperative care: Q&A with Dr. Richard Hodin (Becker’s GI & Endoscopy)
Understanding gastroenterology trends in preoperative care can allow gastroenterologists to better prepare patients for surgery and recovery.
Diet Quality and Risk of Precursors of Early-Onset Colorectal Cancer (Medscape)
Increasing evidence points to hyperinsulinemia, chronic inflammation, and gut dysbiosis as the plausible mechanisms linking diet and CRC.
Gastroenterologist pay drops to $406,000: 15 key statistics (Becker’s GI & Endoscopy)
Gastroenterologist pay dropped to $406,000, the 7th highest-paid specialty, with plastic surgeons beating orthopedic surgeons to the top spot in 2021.

More Hot headlines in GI
CEO of Bold Health (digital GI): “We seek to cover all GI conditions you might want to see a doctor for” (Interview) (NextServices)

Apple unveils automated health data alerts, in-EHR record sharing, fall risk analysis and more (Fierce Healthcare)

Medline sold to private equity firms for $34B, but Northfield company’s management unchanged (Chicago Tribune)

State-of-the-Art Colonoscopy Care Now in Northampton County (LVHN News)

Hackensack University Medical Center and Hackensack Meridian School of Medicine Welcome Howard M. Ross, M.D. as Chair of Surgery/Surgeon-in-Chief (PR Newswire)

Amazon Pharmacy offers half-yearly prescriptions starting at $6 (Reuters)

FDA Grants New Indication for Opdivo for Resected Esophageal or GEJ Cancer (Gastroenterology & Endoscopy News)

Psychobiotics for Patients with Chronic Gastrointestinal Disorders Having Anxiety or Depression Symptoms (Dove Press)

Phillip Stoltenberg, MD, FACP, AGAF, a Gastroenterologist with MNGI Digestive Health (Pro News Report)

Walmart launching drug discount offering in membership program
(Fierce Healthcare)

Motus GI Announces Publication of Pure-Vu® System Clinical Data in Peer-Reviewed Journal BMC Gastroenterology (GlobeNewswire)

Health tech funding snapshot—Data analytics startup Axtria banks $150M; Binx Health nabs $104M for at-home testing (Fierce Healthcare)

Medical cost trend: Behind the numbers 2022 (PwC)

Videos: Interviews with GI Leaders  (NextServices)

_
COVID-19: The Way Forward for Gastroenterology Practices
COVID-19 is a double whammy of both clinical and business disruption. This ebook will help you explore possible scenarios and be a guide in your plans for the future.
button_download
04 Jun 2021

Curated GI articles June 3rd, 2021: NPs perform colonoscopies | DayTwo raises $37M for metabolic disease

Curated GI articles June 3rd, 2021:
NPs perform colonoscopies | DayTwo raises $37M for metabolic disease
DayTwo raises $37m to help manage metabolic diseases through personalized nutrition (NoCamels)
The company’s database of the gut microbiome is also the foundation for the DayTwo Human Discovery Platform, which it claims is the world’s largest and highest resolution microbiome discovery platform.
Scope Forward podcast – CEO of Bold Health (digital GI company) (Episode 26)
Listen to the interviews on the move! Praveen Suthrum’s conversations with GI leaders are now available via the Scope Forward podcast on Apple Podcasts, Spotify and elsewhere.
Gastro Health marks 10th north Virginia acquisition (Becker’s GI & Endoscopy)
Gastro Health now has 10 locations in northern Virginia. It has locations in six states and operates endoscopy centers in five of them.
Saving private practice? Navigating the legal and ethical minefield of physician-private equity deals (MedCity News)
How can they get the investment they need to keep their doors open without ending up drowning in litigation?
3 biggest issues in GI: Q&A with Dr. Andrew Chan (Becker’s GI & Endoscopy)
Cancer screenings and disparities are some of the biggest issues in gastroenterology, according to some GI leaders.
20 Years of PillCam Capsule Endoscopy Innovation (MD+DI)
A Medtronic engineer shares the greatest triumphs and challenges in the PillCam technology’s 20-year evolution.
Digital navigation to automate patient engagement and reduce procedure no-shows (GI & Hepatology News)
Among scheduled outpatient colonoscopies, key metrics like no-show rates and poor bowel preparation can be as high as 25% in some facilities.
More and More Doctors Abandoning Private Practice (Medscape)
Fewer doctors are opting to run their own small private practices, with more seeking jobs in hospitals or larger medical groups, according to a new report.
NPs and PAs Performing Colonoscopies: Why Not? (Medscape)
Highly trained nurse practitioners (NPs) and physician assistants (PAs) are just as capable of performing screening colonoscopies as gastroenterologists: this is the conclusion from a number of studies conducted across both the United States and Europe.
GI and liver diseases linked to alcohol spiked during pandemic (GI & Hepatology News)
Rates of liver and gastrointestinal diseases associated with drinking alcohol rose after the COVID-19 pandemic started, compared with the same period in 2019.
FDA Approves Ozanimod (Zeposia) for Ulcerative Colitis (Medscape)
The US Food and Drug Administration (FDA) has approved ozanimod (Zeposia) for adults with moderately to severely active ulcerative colitis (UC), the company has announced.
Younger age at screening links to lower CRC incidence (Healio)
Endoscopy in patients aged younger than 50 years decreased the incidence of colorectal cancer, according to study estimates reported at Digestive Disease Week.
Video: Stool-based CRC screening promises cost effectiveness (Healio)
Paul Limburg, MD, Mayo Clinic, told Healio adherence rates for stool-based colorectal cancer screening and colonoscopy informed comparative effectiveness and the need for improved screening and follow-up adherence.
To Measure IBD Activity, Sweat the Small Stuff (Gastroenterology & Endoscopy News)
A wrist-worn device can accurately measure inflammatory biomarkers in sweat and may eventually be part of the clinical armamentarium for managing patients with inflammatory bowel disease.
Health-Care Deals Keep Hot Pace as Economy Pushes Past Pandemic (Bloomberg Law)
Health-care mergers and acquisitions continued at a hot pace in April with 207 deals closed or announced, the third month in 2021 that broke the 200-deal threshold.
FDA Approves Guardant360® Liquid Biopsy as CDx for Sotorasib in NSCLC (Guardant Health)
Guardant Health liquid biopsy can help identify the 13 percent of patients harboring the KRAS G12C mutation, a previously undruggable target, who may be appropriate for LUMAKRAS.
The ‘blue poop challenge’ is helping people grade their guts (CNet)
In a “movement” from health science company Zoe, people are eating two blue muffins in the morning, then making note of when their poop comes out blue.
Video: Women leaders key to evading crisis during pandemic (Healio)
Sunanda V. Kane, MD and Uzma D. Siddiqui, MD, FASGE, highlighted their experiences as women in leadership roles during the COVID-19 pandemic.
Preventing endoscopist injuries starts with ergonomics (MDedge)
Latha Alaparthi, MD, noted that female gastroenterologists are at particular risk because they often work with outsize equipment and suboptimal room setup.
Podcast: Bonus episode – Your #DDW2021 recap (AGA)
In this episode of Small Talk, Big Topics, hosts Matthew Whitson and C.S. Tse are joined by AGA Council Chair Dr. Rhonda Souza to recap the 2021 virtual DDW conference.

More Hot headlines in GI
Dr. Scott Ketover: “The future of GI remains bright. Because if it goes in your mouth, it’s in our domain” (Interview) (NextServices)

New Data Finds Novel, Large-Scale PPI Deprescribing Program Safe and Effective (DDW News)

Diet Plays Critical Role in NASH Progressing to Liver Cancer in Mouse Model (UC San Diego Health)

What the pandemic revealed about GI (Becker’s GI & Endoscopy)

Highlights from Digestive Disease Week 2021 (Healio)

Bedfont Scientific Ltd. teams up with GI Cognition to launch Hydrogen and Methane Breath Testing ‘Home Kits’ to help improve Gastric Health remotely (PRNewswire)

The Post-Bariatric Patient With Complications (Gastroenterology & Endoscopy News)

4 Gastro Health moves in 2021 (Becker’s GI & Endoscopy)

GI Symptoms and Chronic Fatigue May Persist Months After COVID-19 (Medscape)

There’s a model for healthcare reform. It’s called Amazon.com (Los Angeles Times)

Blog: My two favorite pandemic tech solutions (Healio)

Surgery trends all gastroenterologists should know (Becker’s GI & Endoscopy)

The Future of COVID-19 Therapies and Vaccines (The Medical Futurist)

3 digital health initiatives Amazon launched in the past 90 days (Becker’s Health IT)

Cleveland Clinic’s Digestive Disease & Surgery Institute names chair (Becker’s GI & Endoscopy)

Videos: Interviews with GI Leaders  (NextServices)

_
COVID-19: The Way Forward for Gastroenterology Practices
COVID-19 is a double whammy of both clinical and business disruption. This ebook will help you explore possible scenarios and be a guide in your plans for the future.
button_download
30 May 2021

Curated GI articles May 28th, 2021: AI in GI startup Docbot funding $8.5M | Gastro Health valuation mid-$900m

Curated GI articles May 28th, 2021:
AI in GI startup Docbot funding $8.5M | Gastro Health valuation mid-$900m
AI impressive as a second set of eyes in colonoscopy (AIinHealthcare)
Researchers have developed a deep convolutional neural network that can identify colorectal polyps with 90% accuracy while ruling out 80% of false flags.
Scope Forward podcast – CEO of Bold Health (digital GI company) (Episode 26)
Listen to the interviews on the move! Praveen Suthrum’s conversations with GI leaders are now available via the Scope Forward podcast on Apple Podcasts, Spotify and elsewhere.
Interview: CEO of Bold Health: “We seek to cover all GI conditions you might want to see a doctor for” (NextServices)
Elena Mustatea is the CEO and founder of Bold Health, a digital GI company that delivers digital therapeutics for the treatment of various GI conditions such as IBS.
What are the most rewarding, challenging factors for gastroenterologists? (Becker’s GI & Endoscopy)
Most gastroenterologists say making the world a better place or finding diagnoses for patients are the most rewarding aspects of their job.
Private equity thriving in gastroenterology: 9 updates (Becker’s GI & Endoscopy)
Private equity has seen consistent success in gastroenterology, with firms like One GI acquiring at least three firms since the start of 2021.
OMERS buys Audax’s Gastro Health at mid-$900m valuation (PE Hub)
Being a first-mover is proving advantageous, with Audax one of the first private equity entrants in GI physician practice management as a result of its early 2016 investment.
How gastroenterologist pay has changed in the past 10 years (Becker’s GI & Endoscopy)
Gastroenterology has consistently been among the top 10 highest-earning specialties in the U.S., with an average annual salary of $406,000 in 2021.
Engine and Giiant Scoop Up Fresh Funding for Cancer and IBD (BioSpace)
After a $10 million seed round in 2018, Engine Biosciences announced its first VC round – a $43 million Series A.
Geneoscopy Announces Publication of Peer-Reviewed Article (BusinessWire)
The article reports high sensitivity of the company’s noninvasive, at-home diagnostic screening test to successfully detect colorectal neoplasms, in average-risk individuals within the intended use population for CRC.
USPSTF Recommendations Guide Payers on Preventive Care Screenings (Health Payer Intelligence)
The latest US Preventive Services Task Force recommendations addressed hypertension, colorectal cancer, and vitamin D deficiency preventive care screenings.
EndoFresh’s disposable endoscopy system greenlighted by FDA (Becker’s GI & Endoscopy)
The device’s approval comes following reports by the FDA on cross contamination risks associated with urological endoscopes and duodenoscopes.
CytoReason and Ferring Pair Up, Using AI to Improve IBD Drug Options (BioSpace)
The purpose is to develop cell-based disease models to accelerate drug discovery and reduce development costs.
AI Toilet Tool Offers Remote Patient Monitoring for Gastrointestinal Health (mHealth Intelligence)
Duke University is developing an artificial intelligence software tool for toilets that uses remote patient monitoring to help manage gastrointestinal issues.
Probiotics: A Review for Clinical Use (Gastroenterology & Endoscopy News)
Just how probiotics may affect various conditions is not completely understood, but several mechanisms have been proposed.
COVID-19’s Gut Connection -How MIS-C complication develops in children, adolescents (Harvard Medical School)
The syndrome can occur several weeks after an initial infection. Symptoms include high fever, abdominal pain, vomiting, diarrhea, rash, and extreme fatigue.
Video: DDW chair recaps noteworthy abstracts from virtual meeting (Healio)
Loren Laine, MD, FACG, chair of the Digestive Disease Week counsel, Yale School of Medicine, highlighted a few presentations from Digestive Disease Week.
STAT+ Conversations: A discussion on health disparities in colorectal cancer with Dr. Fola May (STAT)
A discussion with Dr. Fola May on health disparities and why 45 is the new 50 for screening age.
Colonoscopies Restricted by Pandemic: Worse CRC Outcomes to Come? (Medscape)
After COVID-19 screening policies were implemented, a significantly lower rate of veterans with red-flag signs or symptoms for CRC underwent colonoscopy.
15 Need-to-Know Presentations From DDW 2021 (Medscape)
“We must consider raising our expectations for FIT-positive patients as well as looking for serrated lesions in mt-sDNA-positive patients.” – A Commentary by David A. Johnson, MD.
AI in GI startup Docbot funding $8.5M (Fierce Biotech)
Docbot aims to hit the ground running with a Series A cash infusion and a new CEO—and move forward with clinical trials of its real-time artificial intelligence programs for spotting potential cancers during colonoscopy.

More Hot headlines in GI
Dr. Scott Ketover: “The future of GI remains bright. Because if it goes in your mouth, it’s in our domain” (Interview) (NextServices)

Motus GI’s Pure-Vu System® Adopted by Sinai Hospital of Baltimore (StreetInsider)

Impact of COVID-19 on Gastroenterology Fellowship Training (DocWireNews)

AMSURG and Mount Sinai Health System Release New Research on Early-Onset Colorectal Cancer (Mount Sinai)

Cracking the Racial Disparity Nut (MedPage Today)

Q&A: Understanding altered fecal microbiome in chronic TBI may lead to new treatments (Healio)

Fatty Acid Blocker Does Well in Phase 2 Trial for NASH (Gastroenterology & Endoscopy News)

Allied Digestive Health affiliate leases medical office space (Becker’s GI & Endoscopy)

An Update on Immune Checkpoint Therapy for the Treatment of Lynch Syndrome (Dovepress)

COVID-19 Pandemic Response the Blueprint for Reducing C Difficile Impact (HCPLive)

Video: One-third of IBS-C patients surveyed report worsening of symptoms during COVID-19 (Healio)

6 recent GI exec moves (Becker’s GI & Endoscopy)

FAST Score Can Stratify NASH Risk in Diabetics (Gastroenterology & Endoscopy News)

AGA recommends early use of biologics in some Crohn’s disease patients (Becker’s GI & Endoscopy)

Prebiotic in Development Shows Promise for Reducing GERD Symptoms (Medscape)

Connecticut GI/Hartford HealthCare Named Celiac Center of Excellence (Hartford Healthcare)

Former Surgical Care Affiliates exec named Pinnacle GI Partners CEO (Becker’s GI & Endoscopy)

Videos: Interviews with GI Leaders  (NextServices)

_
COVID-19: The Way Forward for Gastroenterology Practices
COVID-19 is a double whammy of both clinical and business disruption. This ebook will help you explore possible scenarios and be a guide in your plans for the future.
button_download
27 May 2021

CEO of Bold Health (digital GI): “We seek to cover all GI conditions you might want to see a doctor for” (Interview)

Elena Mustatea is the CEO and founder of Bold Health, a digital GI company that delivers digital therapeutics for the treatment of various GI conditions such as IBS. Their first app Zemedy is available in 190 countries. Now, they are hiring GIs and expanding in the US.
In 2018, Forbes listed Elena in a 30 under 30 list.
While private practice GIs are occupied with private equity, the world of digital health has been expanding. In Q1 2021, digital health attracted $9 billion in investments.
In this first-of-its-kind interview, learn more about Bold Health and the world of digital therapeutics, CBT, integrative medicine and the advent of digital health in GI. Elena talks about their business and operational models. She delves into getting paid by insurances.
Digital GI is a practical reality today. This train too is leaving the station.
Invest in your future by listening to this interview (25+min).
◘  Romania to UK to US: Elena’s background and the story behind Bold Health
◘  “We knew there wasn’t much digital health helping GI patients while this being one of the largest condition categories both by spend and also by prevalence”
◘  The mind-gut connection and why it’s important  
◘  What’s the reason that we don’t have enough solutions in this space? 
◘  “I think the system so far hasn’t really provided integrative medicine. We are big fans of the emerging model, where we look at patients as a whole”
◘  “Zemedy (an app to manage IBS) is now available in over 190 countries”
◘  “Standard medicine doesn’t work well with IBS because it is a disorder of the gut-brain link and it’s a functional condition not an organic one”
◘  Clinical outcomes of Zemedy
◘  Working of Bold Health’s business model
“We are set up as a provider that can hire a licensed clinical team”
“We seek to cover all GI conditions that you might want to see a doctor for”
◘  “We focus on being one point of entry for all GI needs in a digitally enabled format”
◘  “We are creating the most efficient, effective, convenient and delightful care for the patients”
◘  What happens when the patient is advised to visit the doctor in-person?
◘  “We are the only end-to-end digital GI care platform”
◘  What is your vision for GI and healthcare as a whole?


The Transcribed Interview:
Praveen Suthrum:  Elena Mustatea, welcome to The Scope Forward Show. Thank you so much for joining me today, you’re the CEO and founder of Bold Health, a digital GI Company. Really warm welcome.
Elena Mustatea:  Thank you so much really delighted to be here and I thank the audience for being here with us today as well.
Praveen Suthrum: You know when I actually saw your profile it seemed like a Mission Impossible movie cutting across different countries. So, you grew up in Romania, then I saw Italy pop up and then Germany and then you founded Bold Health in the UK, and then you were in New York. Now you’re extending Bold Health to the US. Then, of course, you’re part of the Forbes 30 under 30 list. So, congratulations on that. Please tell us the back-story here and what led up to the founding of Bold Health?
Elena Mustatea: Sure. Thank you so much for taking the time to research my background. Indeed I spent time in many countries. I studied in like five different countries and I took that with me in building companies and I always see myself kind of building global companies that make an impact around the world. And I think it’s important to have that international view of things and understanding different systems, different social implications. So, yes I grew up in Romania and I actually remember just growing up with a bunch of digestive symptoms. Lots of abdominal pain, various others and I thought that was normal because most people in my family had IBS, had ulcers. My dad; we almost lost him to an intestinal obstruction was in the emergency room and we were really afraid for him.
And yeah I would see people with all sorts of digestive issues, maybe it was because we didn’t have such a great water system in Romania and so forth at the time. But it took a while for the medical system to have a simple blood test… to tell you have that and then you get antibiotics and it’s gone. So, I’ve seen the benefits of standard medicine in improving gut disease. And later as I was working, I worked in management consulting and investment banking, venture capital, I had a pretty intense, very demanding job, poor lifestyle, working across time zones, taking many flights, working late, you know, eating if I could… I developed IBS – Irritable Bowel Syndrome that really impacted my ability to work productively to enjoy life, to go out, socialize, eat and drink whatever I wanted, it even affected my intimacy. So, I saw this very significant impact on gut symptoms on overall you know quality of life and also on my mental health.
So, really Bold Health was born out of the desire to help other people like me and my family but in general, people suffering from underserved conditions or even mystery conditions that we might not diagnose early enough. We might not know how to treat or they require a more integrative approach. Maybe it’s food as medicine, there’s medication, maybe it’s a psychologist that helps you work through the behavioral aspects, which frankly you know standard medicine doesn’t do today. So, I got together with my co-founder who is a doctor, very passionate doctor about technological innovation in healthcare. He’s run a number of digital health startups. He comes from Nigeria, a very international background as well. We knew there wasn’t much digital health helping GI patients while this being one of the largest condition categories both by spend but also by prevalence. We know 70 percent of American adults will have a recurring GI symptom and about 30 percent will have a diagnosable illness, right? So, very vast condition, are poorly served we believe at the moment and we see that anecdotally from our patients and then very little digitized. So, of course, building a digital health startup in this space felt a no-brainer.
Praveen Suthrum: Elena you talk often about the mind-gut connection. You’ve written about it and that seems to form a foundation for Bold Health as well. Can you share a little bit more?
Elena Mustatea: Sure. So, in the recent years, we’ve been learning a lot more about the gut-brain link connection and dysfunctions of this gut-brain connection. And what it is… it’s a direct link between the central nervous system of our brain and the enteric nervous system of our gut. We don’t know exactly how they’re linked. Some say via the Vagus nerve, there might be other nerve endings that connect the two brains. People say our gut is actually our second brain and evolutionarily, it was our very first brain – around digestion, life-giving digestion, right? And what we know it’s a bi-directional link that the gut affects the brain and the other way around. So, that’s the main insight we leverage in our work… that because our digestive system is responsive to psychological and behavioral factors, we can treat it leveraging behavioral medicine what we call behavioral medicine, and techniques within that are Cognitive Behavioral Therapy and Hypnotherapy. These have the best evidence-based development over the past 20 to 30 years that CBT and Hypnotherapy can improve digestive systems dramatically and actually in conditions like IBS which is the poster child gut-brain dysfunction affecting 15 to 20 percent of people, CBT and hypnotherapy are by far the most effective at around 70 percent efficacy rates. That’s more than prescription drugs, more than diets, more than probiotics, and others.
So, anecdotally a story – one of our collaborators at the University of Pennsylvania, she was telling us that every week she has a patient flying in from Toronto to Philadelphia to get their one-hour CBT with this therapist. And so, it’s a very under-served patient population and through our work, actually, we make these therapies accessible digitally. We aim to deliver the most effective and convenient digital care for GI conditions providing both a virtual care team an integrated virtual care team composed of GI doctors, dietitians, clinical psychologists, and health coaches as well as highly effective digital therapeutics for the self-management of the condition.
Praveen Suthrum: What you said made me wonder, you know it’s such a powerful insight regarding the gut-brain connection. So, my question is how come we don’t see as many solutions? What must be the reason?
Elena Mustatea: Well, first of all, we weren’t around to commercialize these solutions. They were being studied and researched for a very long time and even when we speak to clinicians all around the world. Really they’re like okay I recognize that CBT and Hypnotherapy are highly effective, I’d love to give them to my patients but it’s not really part of the standard of care we don’t have that type of service, you know we barely offer people 10 minutes consultations and a quick prescription. So, simply I think the system hasn’t really provided so far integrative medicine. So, we’re big fans of the emerging model in GI care where we look at the patient as a whole with both mental health, physical health, and a lot of other factors that I mentioned affecting their GI health and overall well-being. So, first of all, you have to innovate by bringing integrative care to people that does recognize the gut-brain link does recognize the importance of lifestyle and good nutrition, and brings in these pillars into care. But we know right now the standard of care, you go to the doctor, you get a medical prescription, and then go home and hope for the best!
So, that’s the innovation integrative care and when you look really at the behavioral interventions, it’s a bit counter-intuitive, right? That you would treat the very physical illness you know people have their deep abdominal, pain diarrhea for days or constipation, huge bloating, they are insensitive to anything they eat and so that’s a bit counterintuitive that by giving them Cognitive Behavioral Therapy and teaching them how to reposition, how they relate to the condition that would significantly reduce symptoms. But what we always did so that it doesn’t sound too alternative is to base everything in science so we collaborate with people at the University of Pennsylvania needing IBS centers in the UK or with Stanford University where there’s existing evidence, where there’s proven protocols and some of the best experts in the field.
Praveen Suthrum: So your first solution was Zemedy which is an app and that was launched just in the UK or is it available outside of the UK too?
Elena Mustatea: So, Zemedy is available in over 190 countries. What we wanted to do with our first solution and Zemedy is a digital care program for IBS – Irritable Bowel Syndrome, what we wanted to do initially is to serve the area of most acute needs which we identified IBS to be that. We saw the largest number of people affected 15- 20 percent of the population. Complete lack of effective treatment. Standard medicine doesn’t work very much in IBS because it’s a disorder of the gut-brain link and it’s a functional condition and not an organic one. So, we wanted to create a program fully digital initially that people can access by a digital app to get therapies that we know work with CBT and Hypnotherapy. They can access it at their fingertips, they can play guided exercises, they can go through patient education, and so forth and really self-manage, and use this app to improve their symptoms at home. So, with that in mind, we launched the app around the world. We recently are more focused on the UK and in the United States for commercialization but we want to make our apps available widely so that underserved patients can easily access them. So, this rollout of Zemedy that’s across so many countries.
Praveen Suthrum: What are the outcomes that you’re seeing?
Elena Mustatea: Absolutely. So, we see incredible clinical outcomes from Zemedy. At the moment it’s a fully digital intervention for IBS based on CBT and Hypnotherapy as I mentioned and we already knew from the evidence that the effects we can see are improvement in GI symptoms, improvement in mental health scores like – anxiety, depression, and stress, quality of life and a few others like visceral anxiety, fear of food, generally improved health. So, we’ve actually just published a paper in JMIR (Journal of Medical Internet Research) our first randomized controlled trial with the University of Pennsylvania, where we had 120 patients in two arms – the intervention arm on Zemedy and the waitlist where we saw clinically significant improvement across all of the secondary and primary outcomes of disease. Over 66 percent of patients in the clinical trial saw clinically significant improvement in their GI symptoms. For example in their quality of life and not only that we looked at three months follow-up and we saw that those courses were maintained. So, the benefits of an intervention behavioral psycho-behavioral intervention are magnificent because not only do you get that immediate impact or after a few weeks on the program, but that will be maintained over months and even years.
Praveen Suthrum: So, a common question that comes up in the GI circles you know when it comes to Cognitive Behavioral Therapy or anything that’s outside of the mainstream insurance domain is who will pay for it? In other words, what is your business model?
Elena Mustatea: Sure.  Before that, I’d say you know where we start fundamentally is that we believe in value-based care that delivers the best outcomes for the patient and puts the patient at the center of care. So that’s very important for us not only to get reimbursement for our solutions but also to make it free or covered for the patients while they can be sure that they’re getting the best treatment and the best care they can. So, our model is actually hybrid so we provide a virtual care team telehealth access to different clinicians and then the digital therapeutic for the chronic self-management of the illness so we can get paid for those altogether or separately. For example for the digital therapeutic in some instances ultimately our model is B2B we seek to have coverage and reimbursement by self-insured employers or by health plans and insurers.
We also offer at the moment, until there’s broad coverage around the nation, patients can also buy directly from us. But ultimately we are focused on securing reimbursement across all 50 states. And we function both as a medical provider, so we can charge on claims as well as a technology company. So, for example, we can sell the software – the digital therapeutic on its own. So, then the operational implications is that we’re set up as a provider that can hire a clinical team, licensed clinicians, like dietitians or therapists and GI doctors and nurses while we also have a tech team, we have an R&D team under the parent tech company. So that’s a very interesting challenge to have – to coordinate this type of team and really two organizations that comes under one but it’s necessary so that we’re able to deliver care digitally.
Praveen Suthrum: With this type of model would you be continuing to focus on IBS or would you expand to other GI conditions in the US?
Elena Mustatea: Absolutely. So, we are a diversified GI provider. So, we seek to cover all GI conditions that you might want to see a doctor for. And IBS was our first proof of concept. Digital therapeutics condition area, we built the evidence, we’re building a portfolio of digital therapeutics across other conditions like inflammatory bowel disease and Crohn’s Colitis. We have another product for children with functional abdominal pain. So, not only do we cover multiple conditions, we also cover the whole family, both the pediatric population and adults. And then really we seek to be end-to-end GI care. So, from diagnostics to consultation to ongoing care support to digital therapies but also you know medication, prescriptions, and adherence, and so forth. So, being kind of one point of entry for all GI needs wherever possible in a digital or digitally-enabled format.
Praveen Suthrum: You know when a patient wants to be seen by you or when I say you, I mean either Bold Health or Zemedy or one of the solutions, would they be seen by a digital interface? An algorithm? Or a physician? Or all of it?
Elena Mustatea: All of it! So, we’re creating the most efficient care as well so the most convenient and delightful for the patient, the most effective, right? We’re all trying to improve GI care here. And the most cost-effective GI solutions in care. So, the way to do that… you want to leverage technology and digital as much as possible. So, you mentioned triage, right? Or even having AI algorithms that get the patient data either from here. Or they fill out an assessment and then get triage to the right clinician or the right treatment for them. And then we want to leverage technology at every step of the way and data. And of course with digital therapeutics, we even delivered therapies digitally.
But yeah, to answer more specifically we do an assessment upfront where we get the patient data their symptoms, and so forth, and then we empower the clinician that will see them with that data. So, it’s very effective they already have everything upfront and they can spend time providing quality care to the patient. And what’s interesting is we offer a care navigator, that at the moment would be a GI nurse that understands both GI conditions very well and all the different components of integrative care. And all the different clinicians that we might offer within the team and might serve the patient and after doing this assessment, the care navigator, the GI nurse will decide – does this patient need to see the GI doctor? Or maybe they should be put on Zemedy, on the digital therapeutic alongside seeing a dietitian.
So not everybody gets the same it’s a personalized care journey-based on data on the patient and what makes most sense for them and it’s a very high touch concierge type of service and even though this sounds like this cannot be cost-effective, because you give access to a full integrative team and you build whole technology infrastructure, we know from evidence that actually integrative care will be the most cost-effective because you prevent a lot of costs down the line when the patient gets much better or even enters remission closer upfront or in the first year or immediately after diagnosis.
Praveen Suthrum: So, let’s say a patient is seen virtually and the doctor determines that this patient has to go through a physical exam needs to be seen in person, or has to go through a colonoscopy what happens at that time do you refer the case to somebody else or would you also employ GI doctors to see them in person?
Elena Mustatea: Absolutely, so that’s a brilliant question and it’s very important, right? We recognize that in GI care many patients do have to get their colonoscopies on a recurring basis for example people with Inflammatory Bowel Disease that need to be monitored and there will be instances to do these invasive tests or see a GI doctor face-to-face. So, what we’re developing is a network of premium partners for in-network referrals so that around the country and in various in-networks of each health plan. For example, we can identify those clinicians that are high-performing that have good reviews, that we know are compatible with this integrative model of care, and see things in a let’s say progressive way and can refer patients into them so we see ourselves augmenting  in-person medicine and standard care and supporting patients for this chronic journey. Because ultimately care is what happens you know after you’ve seen the doctor. And often you know standard care pathways won’t include a dietitian or won’t include a GI psychologist that we can offer to really augment and make better what patients might get from their primary care doctor or their main GI doctor.
Praveen Suthrum: I take it you would move in the direction of FDA approval?
Elena Mustatea: That’s not correct. So, at the moment we don’t have plans to go through FDA approval. We are a Chronic Care Management platform for gastrointestinal conditions we provide digital care pathways and for the digital therapy that we digitize, we position it as a self-management program ultimately CBT therapists or Hypnotherapists are not FDA approved so almost in that vein our intervention doesn’t need to be FDA approved.
Praveen Suthrum: Okay, that’s helpful. So, I’ve learned that Oshi Health is also positioning itself as a digital GI platform or digital telemedicine platform. How does Bold Health differ from what they’re doing? Or is it similar and more broadly who do you see as competition for what you do?
Elena Mustatea: Absolutely, so to clarify we’re the only end-to-end GI care digital platform. I would say and the two components are the virtual care integrative team – let’s say telemedicine for GI and then the portfolio of digital therapies for self-management for self-care that we give our patients access to. So, in that sense players like Oshi Health and GI-on-demand as well  I think, are building a similar platform to Oshi that is virtual care, telemedicine/telehealth giving access to the integrative care team, which is fantastic! We believe in that and we’re very happy that multiple digital providers are emerging.
And then on digital therapeutics you know we mentioned Mahana, they do that. And now have the IBS product, they might go into other condition areas. The other competitor I would like to mention is Vivante Health. So, they’re also in the B2B space they’re selling into employers and insurers with a bit of a hybrid model where they have a care team with dietitian and health coach and then they offer an app and there’s information psycho-education and so forth. So, they’re a bit of a hybrid between the two but I’d say we’re the only ones set up both as a provider and offering the digital therapeutics.
Praveen Suthrum: Okay excellent, Elena let me ask you what is your vision for GI as a space and maybe healthcare as a whole?
Elena Mustatea: Absolutely. So, we believe in the world where people live free of the burden of chronic conditions more generally and when you do have chronic conditions you can get the right care immediately excessively and you can feel much better so that you can have a full life and limitless life as we call it at Bold Health. So, that’s a division of the world. In terms of GI care, we believe things can be made a lot better where patients can get a diagnosis faster. We know today they have to often wait over four years to get an IBS or IBD diagnosis. We find that unacceptable. Also in the world today, people don’t get access to effective therapies like CBT or Hypnotherapy even when they’re the most effective therapies. So, we believe in that world where you get access to the right treatment as soon as you get diagnosed, as soon as you have that need, and healthcare becomes not only very convenient but delightful, right? Where you know you’re being taken care of, you have a care team that you can have a relationship with, you feel supported.
And that’s something what we’ve seen with our app for example, in the feedback, some people tell us “I feel like this is my best friend,  it understands what I go through, it knows my condition in and out and it can give me advice, it just tells the story that I’m living.” So, it’s really interesting how patients are coming at the center of care. We see the consumerization of healthcare where we expect you know really good service, really high-quality products which would be the care and the therapies and treatments we get and ultimately much better outcomes. So, I believe in GI we can produce better outcomes, faster with reduced costs. Ultimately, I’d say the world I see for GI is really integrative care in GI where we look at the patient as a whole, we understand the gut-brain link, we leverage it to treat people better and provide dietary support, psychological, support GI medication for the most optimal outcome. And we hope we’re part of creating that world I would say, all those different aspects of that vision where our platform builds towards that.
Praveen Suthrum: Wonderful Elena, thank you so much for sharing your views and sharing this vision. Were there any final comments that you’d like to share?
Elena Mustatea: No, I would just want to really thank you for the invite. I’m super happy that I was able to share our work at Bold Health and our vision for better GI care and thank everyone for your attention.

_


By Praveen Suthrum, President & Co-Founder, NextServices. 

COVID-19: The Way Forward for Gastroenterology Practices
COVID-19 is a double whammy of both clinical and business disruption. This ebook will help you explore possible scenarios and be a guide in your plans for the future.
button_download
20 May 2021

Curated GI articles May 19th, 2021: 63% of gastroenterologists saw a permanent decline in volume (Becker’s ASC)

Curated GI articles May 19th, 2021:
63% of gastroenterologists saw a permanent decline in volume (Becker’s ASC)
E/M Coding for 2021: What’s New and Different—Part 1 (Gastroenterology & Endoscopy News)
Some aspects of these revisions took effect for telehealth services since spring 2020 for Medicare, but now all payors should be adopting the changes.
14 Takeaways from Exact Sciences quarterly earnings call (NextServices)
The company expects to make $1.7 billion in revenues in 2021. COVID-19 testing contributed to $32.3 million.
63% of gastroenterologists saw a permanent decline in patient volume (Becker’s GI & Endoscopy)
Fifty-two percent of self-employed gastroenterologists saw a 1-25 percent decline in patient volume that they believe is permanent.
Medscape Gastroenterologist Compensation Report 2021 (Medscape)
While the worst business days are over for some physicians, others still struggle to recover.
USPSTF Final Recommendation on CRC Screening: 45 Is the New 50 (Medscape)
Screening for colorectal cancer in the US should now begin at the age of 45 in recognition of the growing number of adults under the age of 50 who are developing and dying from the disease.
Experts Caution on False Positives in AI (Gastroenterology & Endoscopy News)
Experts fear that emerging systems of computer-aided polyp detection may be generating so many false-positive findings that gastroenterologists who use the technology risk burnout.
Docbot Announces Upcoming Oral Presentation at Digestive Disease Week (DDW) 2021 (Valdosta Daily Times)
Title of presentation: Detection of Early Esophageal Neoplasia in Barrett’s Esophagus using Real-Time Artificial Intelligence: A Multicenter External Video Validation Study.
COVID’s Big Impact Made a Fairly Small Dent in GI Earnings (Medscape)
Despite the shutdowns and plummeting patient volumes early in the COVID-19 pandemic, gastroenterologists’ earnings were just 3.1% lower in 2020 than in 2019.
IBD Online: What Do Patients Search For? (Medscape)
The researchers suspected that social media users with IBD were looking for information they weren’t getting from their provider, so the researchers set out to identify those specific unmet needs.
Collaboration aims to improves diagnosis of gut health problems (MedTech Innovation)
Digestive health is also cited as one of the leading causes of work absenteeism and global direct and indirect costs are estimated at $21 billion annually.
EureKARE raises $60M to create EU synbio and microbiome startups (Fierce Biotech)
EureKARE has raised a $60 million series A round to fund the creation and advancement of synthetic biology and microbiome startups.
Specialty Excellence Awards 2021 Gastrointestinal Care (Healthgrades)
Healthgrades published its 2021 Specialty Excellence Awards on May 11 covering 16 service lines, including the top hospitals for gastrointestinal care.
Video: How COVID-19 transformed the future of medicine (TED.com)
Daniel Kraft explains how advancements like AI-infused antiviral discoveries and laboratory-level diagnostic tools accessible via smartphones are paving the way for a more connected and data-driven future of medicine.
ACG publishes guidelines for preferred treatment of C. difficile infection (Healio)
ACG developed guidelines for the preferred management of adults with Clostridioides difficile infection, published in the American Journal of Gastroenterology.
$3M ASC proposed in Vermont (Becker’s ASC Review)
The Collaborative Surgery Center will be about 9,000-square-feet with four operating rooms. It’s expected to be a multispecialty center.
Do self-employed or employed gastroenterologists earn more? (Becker’s GI & Endoscopy)
Self-employed gastroenterologists made $3,000 more annually than employed gastroenterologists.
Venture Firm Behind Livongo Launches $150 Million Consumer Health Fund (Forbes)
Livongo, the chronic disease management company incubated in Tullman and Shapiro’s offices, in an $18.5 billion deal, the duo’s firm has closed a $150 million fund to find the next digital health winner.
Post-COVID-19 GI Symptoms: Are We in for the Long Haul? (Medscape)
Dr David Johnson, professor of medicine and chief of gastroenterology at Eastern Virginia Medical School in Norfolk, Virginia, talks about the gastrointestinal (GI) manifestations of so-called long-haul COVID-19.

 


More Hot headlines in GI
Dr. Scott Ketover: “The future of GI remains bright. Because if it goes in your mouth, it’s in our domain” (Interview) (NextServices)

Multi-gene testing could detect more hereditary cancer syndromes (EurekAlert)

IBD-Associated Colorectal Cancer Genetically Unrelated to Sporadic Type (Medscape)

A natural evolution: How a transition to single-use endoscopy improves clinician and patient experience (Becker’s GI & Endoscopy News)

CABYR Isoforms As Targets for Specific Immunotherapy (MedPage Today)

WELL Health Technologies Stock Making Waves (Benzinga)

Genfit announces the release of NASHnext (Healio)

CRISPR and the End of Genetic Diseases (Medscape)

Woman diagnosed with stage 3 CRC had colonoscopy canceled 3 times (Business Wire)

Healthcare Delivery Disrupted? The Rise Of Platforms In Healthcare (Forbes)

Sharma’s Endoscopy Insights: Tattoos, Functional Disorders and Artificial Intelligence (Gastroenterology & Endoscopy News)

Volume on consults for alcohol-related GI, liver diseases remain elevated throughout COVID-19 (Healio)

Breathing Through the Rectum Saves Oxygen-Starved Mice and Pigs (The New York Times)

Mayo Clinic ‘AI factory’ has dozens of projects underway (Becker’s Health IT)

April top 10 in GI: colorectal cancer, AGA guidance, IBD (Healio)

Videos: Interviews with GI Leaders  (NextServices)

_
COVID-19: The Way Forward for Gastroenterology Practices
COVID-19 is a double whammy of both clinical and business disruption. This ebook will help you explore possible scenarios and be a guide in your plans for the future.
button_download
[Free Ebook]
[Free Ebook]
[Free Ebook]
[Free Ebook]
[Infographic]
[Infographic]
[FREE GUIDE]
[FREE GUIDE]
[HOW TO GROW YOUR LAB THROUGH REFERRALS]
[HOW TO GROW YOUR LAB THROUGH REFERRALS]
[Adenoma Detection Rate Infographic]
[Adenoma Detection Rate Infographic]
[Referrals: Your Most Powerful Network]
[Referrals: Your Most Powerful Network]
[The Ultimate Guide To Boost Your Online Ratings And Grow Your Patient Volume]
[The Ultimate Guide To Boost Your Online Ratings And Grow Your Patient Volume]
[The Ultimate 13-Point Checklist To Increase Patient Volume]
[</span></span></span></span></span></span></span></span></span></span></span></span><span style="font-family: Lato;"><span style="font-size: 20px;">The Ultimate 13-Point Checklist To Increase Patient Volume</span></span><span style="font-family: Lato;"><span style="font-family: Lato;"><span style="font-family: Lato;"><span style="font-family: Lato;"><span style="font-size: 20px;">]
The Handy AR Bundle - 4 pre-designed templates to help you get paid faster]
[ </span></span></span></span></span></span></span></span></span><span style="font-family: Lato;"><span style="font-size: 20px;">The Handy AR Bundle - 4 pre-designed templates to help you get paid faster</span></span><span style="font-family: Lato;"><span style="font-family: Lato;"><span style="font-family: Lato;"><span style="font-family: Lato;"><span style="font-size: 20px;">]